Recent Grants 

The Office of Grants and Sponsored Programs would like to convey our pride and appreciation for the awards received with a project start date of April 1, 2014 to September 30, 2014.

Primary
Investigator

Title of Award

Awarding Agency

Andrea Orsey, MD

Pilot Yoga Intervention: Pediatric Cancer Patients' Sleep and Life Quality and Parents' Wellbeing

University of Connecticut / University of Connecticut Health Center

Christine Finck, MD

Optimal Derivation of Murine Embryonic Distal Airway Stem Cells

U.S. Department of Health and Human Services, National Institutes of Health / National Heart, Lung and Blood Institute / University of Connecticut Health Center (UCHC)

Christine Ohannessian, PhD

Adaptive Treatment for Adolescent Cannabis Use Disorder

National Institutes of Health / University of Connecticut Health Center (UCHC)

Christine Ohannessian, PhD

Treatment of Co-occuring Alcohol Use Disorder & Depression/Anxiety Disorders

National Institutes of Health / University of Connecticut Health Center (UCHC)

Craig Lapin, MD

Nurse & Nutritionist 2014-2015

Cystic Fibrosis Foundation

Donna Boruchov, MD

ATHN Data Quality Counts 2014-2015

American Thrombosis Hemostatis Network

Donna Boruchov, MD

CT Sickle Cell Consortium 2014-2015

Connecticut Department of Public Health / Hospital for Special Care

Donna Boruchov, MD

Sickle Cell 2014-2015

Connecticut Department of Public Health

Fernando Ferrer, MD

Sphingosine -1 -Phosphate Pathway Based Therapy for Neuroblastoma

U.S. Department of Health and Human Services, National Institutes of Health / National Cancer Institute

Hilda Slivka, MD

Lead Clinic 2014-2015

Connecticut Department of Public Health

James Parker, MD

Public Health Preparedness 2014-2015

Connecticut Department of Public Health

Juan Salazar, MD

Mechanism of Impaired Mycobacteria Sensing by TLR2 & TLR4 Polymorphic Variants

National Institutes of Health / University of Connecticut Health Center (UCHC)

Juan Salazar, MD

Phagosomal Signals Shape 2014-2015

National Institutes of Health / University of Connecticut Health Center (UCHC)

Juan Salazar, MD

Ryan White D 2014-2015

U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) / University of Connecticut Health Center (UCHC)

Marilyn Sanders, MD

March of Dimes 2014

March of Dimes

Melissa Santos, PhD

CICATS Pain and Weight Treatment

Connecticut Institute for Clinical and Translational Science (CICATS)

Michelle Cloutier, MD

DPH - Easy Breathing Program 2014-2015

Connecticut Department of Public Health

Nina Livingston, MD

DCF-SCAN Pediatrician 2014-2015

National Children's Alliance / St. Francis Hospital

Paul Dworkin, MD

Care Coordination Collaborative

Connecticut Department of Public Health

Paul Dworkin, MD

Hartford Blueprint Project 2014-2015

Connecticut Department of Public Health / City of Hartford

Paul Dworkin, MD

Use of a National Affiliate Network to Diffuse System Innovation to Promote Vulnerable Children's Optimal Healthy Development

W.K. Kellogg Foundation

Richard Skinner, MD

Dental Clinic 2014-2015

U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) / University of Connecticut Health Center (UCHC)

Thyde Dumont-Mathieu, MD

Early Detection of Pervasive Developmental Disorders

National Institutes of Health / University of Connecticut

William Zempsky, MD

Inpatient Massage Therapy Program

George A. & Grace L. Long Foundation

Garry Lapidus, PA-C

Addressing Lift Assist Calls to Reduce Elderly Falls 2014-2015

Connecticut Department of Social Services / Yale New Haven Hospital

Garry Lapidus, PA-C

Intimate Partner Violence and Child Maltreatment

Connecticut Department of Children and Families

Joanna Bogin, MS

Help Me Grow - Vermont Department of Health

U.S. Department of Education / Vermont Department of Health

Joanna Bogin, MS

Professional Services Contract from Wyoming Department of Health

U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) / Wyoming Department of Health

Joanna Bogin, MS

Professional and Technical Services Contract from State of Minnesota

U.S. Department of Education, Office of Special Education and Rehabilitative Services / Minnesota Department of Education

Kevin Borrup, JD, MPA

Look Before You Look Education Campaign

Connecticut Department of Transportation

Kevin Borrup, JD, MPA

Teen Driving Safety: Capstone Project

All State Foundation

Kyle Kostyun, MS, ATC

Athletic Training Residency

DJO Global, Inc.

Michael Tortora

Public Health Preparedness 2014-2015

Connecticut Department of Public Health

Susan Roman, MPH

Care Coordination

Connecticut Department of Public Health

Susan Roman, MPH

Bioterrorism / Public Health 2014-2015

Connecticut Department of Public Health

Susan Roman, MPH

Husky Plus 2014-2015 Amendment

Connecticut Department of Social Services

New Clinical Trials

Congratulations to the PIs whose studies have recently opened: 

Study Name

Sponsor

PI

Division

A three-armed, randomized, double blind, placebo controlled study of the efficacy and safety of two trough ranges of everolimus as adjunctive therapy in patients with tuberous sclerosis complex who have refractory partial onset seizures.

Novartis Pharmaceutical Corporation

Francis DiMario, MD

Neurology

A phase 1b open label study to assess the safety and pharmacokinetics of subcutaneously administered golimumab, a human anti-TNF antibody, in pediatric subjects with moderately to severely active ulcerative colitis.

Janssen Research & Development LLC

Jeffrey Hyams, MD

Gastroenterology

Registrat MAPI: VTPP 510

Registrat-MAPI

Craig Lapin, MD

Pulmonary Medicine

A phase 1b, open label, multicenter study to investigate the pharmacokinetics, pharmacodynamics and safety of Tocilizumab following subcutaneous administration to patients with polyarticular-course juvenile idiopathic arthritis.

Hoffman-La Roche Limited

Lawrence Zemel, MD

Rheumatology

A phase 1b, open label, multicenter study to investigate the pharmacokinetics, pharmacodynamics and safety of Tocilizumab following subcutaneous administration to patients with systemic juvenile idiopathic arthritis.

Hoffman-La Roche Limited

Lawrence Zemel, MD

Rheumatology

Single-dose study to evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in pediatric subjects at risk for a venous or arterial thrombotic disorder.

Bristol Myers Squibb Oncology

Donna Boruchov, MD

Hematology/Oncology

A phase 3, randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of lumacaftor in combination with ivacaftor in subjects aged 12 years or older with cystic fibrosis, homozygous for the F508-del-CFTR mutation.

Vertex Pharmaceuticals, Inc.

Craig Lapin, MD

Pulmonary Medicine

Pediatric patients with acute hematogenous osteomyelitis.

Cubist Pharmaceuticals, Inc.

Nicholas Bennett, MD

Infectious Disease

Pediatric intravenous versus oral antibiotic therapy.

Children's Hospital of Philadelphia

Ilana Waynik, MD

Inpatient Management Team

CCFA Partners-Pediatrics

Emory University

Jeffrey Hyams, MD

Gastroenterology

A prospective, randomized, double blind, sham controlled, multi center, phase 3 study of OTO-201 given as a single intratympanic injection for intra-operative treatment of middle ear effusion in pediatric subjects requiring tympanostomy tube placement.

Otonomy, Inc.

Scott Schoem, MD

Otolaryngology

Randomized, parallel dose, phase 1/2 safety and pharmacokinetics study of inhaled laninamivir octanoate twincaps dry powder inhaler in children with naturally acquired influenze A or B.

PPD Development, Inc.

Nicholas Bennett, MD

Infectious Disease

A phase 3, multicenter, open label study to evaluate pharmacokinetics, efficacy and safety of Abatacept administered subcutaneously in children and adolescents with active polyarticular juvenile idiopathic arthritis and inadequate response to biologic or non-biologic disease modifying anti-rheumic drugs.

Bristol Myers Squibb

Lawrence Zemel, MD

Rheumatology